MANKIND / NSE / Biotechnology & Drugs
Mankind Pharma
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High2,726.75
Target Low1,909.9
Target Mean2.19
Target Median48.44
Risk Metrics
Overall RiskBalanced risk
Board Risk28.9
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Mankind Pharma divests Broadway Hospitality for ₹49 Cr, plans €5 Million Netherlands unit scanx.trade
799MPL26A Bond Profile — Key Metrics TradingView
Mankind Pharma to set up Netherlands subsidiary for R&D investments Indian Pharma Post
Mankind Pharma Ltd is Rated Hold MarketsMojo
Analysts Are Updating Their Mankind Pharma Limited (NSE:MANKIND) Estimates After Its Yearly Results simplywall.st
Pharma Majors Shift Focus to Chronic Care as Markets Grow Whalesbook
Stock FAQs
What is the symbol and ISIN of Mankind Pharma?
Mankind Pharma has the symbol MANKIND and ISIN - INE634S01028.
What is the current price of Mankind Pharma?
Mankind Pharma is currently trading at INR 2,484.20.
What are the year high and year low of Mankind Pharma?
Mankind Pharma has a year high of INR 2,726.75 and a year low of INR 1,909.90.
What is the market capitalization of Mankind Pharma?
Mankind Pharma has a market capitalization of INR 1.03 lakh crore.
What is the P/E ratio of Mankind Pharma?
Mankind Pharma has a P/E ratio of 43.28.
What is the dividend yield of Mankind Pharma?
Mankind Pharma has a dividend yield of 0.04%.
How is the financial performance of Mankind Pharma based on revenue, net income, and EPS?
Mankind Pharma has revenue of INR 1,42,776.40 crore, net income of INR 19,129.30 crore, and EPS of INR 48.85.
What is the book value of Mankind Pharma?
Mankind Pharma has a book value of INR 4.04.
What is the debt-to-equity ratio of Mankind Pharma?
Mankind Pharma has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Mankind Pharma?
Mankind Pharma has a price-to-book ratio of 614.90 and a price-to-sales ratio of 0.72.
© SharekeyX | Rusaka Technologies 2024-2026